Assessment of the Circulating Tumor Cells and Microsatellite Instability in Colorectal Cancer Patients: Prognostic and Diagnostic Value

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2017. Bethesda, MD: National Cancer Institute. Available from: https://seer.cancer.gov/csr/1975_2017/.
   Google Scholar
• Graham JS, Cassidy J. Adjuvant therapy in colon cancer. Expert Rev Anticancer Ther. 2012;12:99–109. doi:10.1586/era.11.189
   PubMed Web of Science ®Google Scholar
• Hammond WA, Swaika A, Mody K. Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol. 2016;8:57–84. doi:10.1177/1758834015614530
   PubMed Web of Science ®Google Scholar
• Kievit J, Bruinvels DJ. Detection of recurrence after surgery for colorectal cancer. Eur J Cancer. 1995;31A:1222–1225. doi:10.1016/0959-8049(95)00155-C
   PubMed Web of Science ®Google Scholar
• Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531. doi:10.1038/nrclinonc.2017.14
   PubMed Web of Science ®Google Scholar
• Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014;14(9):623–631. doi:10.1038/nrc3820
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Clin Oncol. 2008;26:3213–3221.
   Web of Science ®Google Scholar
• Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. InSeminars Oncol. 2006;33:9–14. WB Saunders.
   Web of Science ®Google Scholar
• De Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14(19):6302–6309. doi:10.1158/1078-0432.CCR-08-0872
   PubMed Web of Science ®Google Scholar
• Ribeiro-Samy S, Oliveira MI, Pereira-Veiga T, et al. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients. Sci Rep. 2019;9(1):8032. doi:10.1038/s41598-019-44401-1
   PubMedGoogle Scholar
• Ward R, Meagher A, Tomlinson I, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001;48:821–829. doi:10.1136/gut.48.6.821
   PubMed Web of Science ®Google Scholar
• Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10(4):293–300. doi:10.2353/jmoldx.2008.080031
   PubMed Web of Science ®Google Scholar
• Zeinalian M, Hashemzadeh-Chaleshtori M, Salehi R, Emami MH. Clinical aspects of microsatellite instability testing in colorectal Cancer. Adv Biomed Res. 2018;7:7. doi:10.4103/abr.abr_185_16
   PubMedGoogle Scholar
• Zarkavelis G, Boussios S, Papadaki A, Katsanos KH, Christodoulou DK, Pentheroudakis G. Current and future biomarkers in colorectal cancer. Ann Gastroenterol. 2017;30(6):613–621. doi:10.20524/aog.2017.0191
   PubMed Web of Science ®Google Scholar
• Bahnassy AA, Salem SE, Mohanad M, et al. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: a comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology). Exp Mol Pathol. 2019;106:90–101. doi:10.1016/j.yexmp.2018.12.006
   PubMed Web of Science ®Google Scholar
• Zekri AN, Khaled HM, Mohammed MB, et al. Microsatellite instability profiling in Egyptian bladder cancer patients: a pilot study. Curr Probl Cancer. 2019;43(6):100472. doi:10.1016/j.currproblcancer.2019.03.002
   PubMed Web of Science ®Google Scholar
• Scripcariu V, Scripcariu DV, Filip B, Gavrilescu MM, Muşină AM, Volovăţ C. “ Liquid Biopsy”-Is it a Feasible Option in Colorectal Cancer? Chirurgia. 2019;114(2):162–166. doi:10.21614/chirurgia.114.2.162
   PubMed Web of Science ®Google Scholar
• Huang MY, Tsai HL, Huang JJ, Wang JY. Clinical implications and future perspectives of circulating tumor cells and biomarkers in clinical outcomes of colorectal cancer. Transl Oncol. 2016;9(4):340–347. doi:10.1016/j.tranon.2016.06.006
   PubMed Web of Science ®Google Scholar
• Lu CY, Uen YH, Tsai HL, et al. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. Br J Cancer. 2011;104(7):1178–1184. doi:10.1038/bjc.2011.40
   PubMed Web of Science ®Google Scholar
• Yang C, Zou K, Zheng L, Xiong B. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review. BMC Cancer. 2017;17(1):725. doi:10.1186/s12885-017-3704-8
   PubMedGoogle Scholar
• Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138(5):1714–1726. doi:10.1053/j.gastro.2010.01.008
   PubMed Web of Science ®Google Scholar
• Kaifi JT, Kunkel M, Dicker DT, et al. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver. Cancer Biol Ther. 2015;16(5):690–698. doi:10.1080/15384047.2015.1026508
   PubMed Web of Science ®Google Scholar
• Huang X, Gao P, Song Y, et al. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer. BMC Cancer. 2015;15(1):202. doi:10.1186/s12885-015-1218-9
   PubMed Web of Science ®Google Scholar
• Molnar B, Sipos F, Galamb O, Tulassay Z. Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients. Dig Dis. 2003;21(4):320–325. doi:10.1159/000075355
   PubMed Web of Science ®Google Scholar
• Lim SH, Becker TM, Chua W, et al. Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer. Cancer Lett. 2014;346(1):24–33. doi:10.1016/j.canlet.2013.12.019
   PubMed Web of Science ®Google Scholar
• Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: a review. Cancer Treat Rev. 2016;51:19–26. doi:10.1016/j.ctrv.2016.10.005
   PubMed Web of Science ®Google Scholar
• Roth AD, Tejpar S, Delorenzi M, et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol. 2010;28:466–474. doi:10.1200/JCO.2009.23.3452
   PubMed Web of Science ®Google Scholar
• Koopman M, Kortman GA, Mekenkamp L, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100(2):266–273. doi:10.1038/sj.bjc.6604867
   PubMed Web of Science ®Google Scholar
• Mohan HM, Ryan E, Balasubramanian I, et al. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer. Eur J Surg Oncol. 2016;42(11):1680–1686. doi:10.1016/j.ejso.2016.05.013
   PubMed Web of Science ®Google Scholar
• Srdjan M, Jadranka A, Ivan D, et al. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma. Indian J Med Res. 2016;143(Suppl 1):S104. doi:10.4103/0971-5916.191801
   PubMedGoogle Scholar
• Dubey AP, Vishwanath S, Nikhil P, Rathore A, Pathak A. Microsatellite instability in stage II colorectal cancer: an Indian perspective. Indian J Cancer. 2016;53(4):513. doi:10.4103/0019-509X.204772
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Iijima T, Wakaume R, et al. Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer. PLoS One. 2019;14(4):e0215513. doi:10.1371/journal.pone.0215513
   PubMed Web of Science ®Google Scholar
• Benatti P, Gafà R, Barana D, et al. Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res. 2005;11(23):8332–8340. doi:10.1158/1078-0432.CCR-05-1030
   PubMed Web of Science ®Google Scholar
• Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer. 2010;46(15):2788–2798. doi:10.1016/j.ejca.2010.05.009
   PubMed Web of Science ®Google Scholar
• Müller CI, Schulmann K, Reinacher-Schick A, et al. Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group. Int J Colorectal Dis. 2008;23(11):1033–1039. doi:10.1007/s00384-008-0504-2
   PubMed Web of Science ®Google Scholar
• Battaglin F, Naseem M, Lenz HJ, Salem ME. Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives. Clin Adv Hematology Oncol. 2018;16(11):735–745.
   PubMed Web of Science ®Google Scholar
• Kim NK. Is a microsatellite instability still useful for tailored treatment in stage II and III colon cancer? Ann Coloproctol. 2014;30:5–6. doi:10.3393/ac.2014.30.1.5
   PubMedGoogle Scholar
• Chong LC, Townsend AR, Young J, et al. Outcomes for metastatic colorectal cancer based on microsatellite instability: results from the south australian metastatic colorectal cancer registry. Target Oncol. 2019;14(1):85–91. doi:10.1007/s11523-018-0615-9
   PubMed Web of Science ®Google Scholar